479 related articles for article (PubMed ID: 16873605)
1. Pharmacological characterization of novel alpha-Calcitonin Gene-Related Peptide (CGRP) receptor peptide antagonists that are selective for human CGRP receptors.
Taylor CK; Smith DD; Hulce M; Abel PW
J Pharmacol Exp Ther; 2006 Nov; 319(2):749-57. PubMed ID: 16873605
[TBL] [Abstract][Full Text] [Related]
2. Functional calcitonin gene-related peptide subtype 2 receptors in porcine coronary arteries are identified as calcitonin gene-related peptide subtype 1 receptors by radioligand binding and reverse transcription-polymerase chain reaction.
Rorabaugh BR; Scofield MA; Smith DD; Jeffries WB; Abel PW
J Pharmacol Exp Ther; 2001 Dec; 299(3):1086-94. PubMed ID: 11714898
[TBL] [Abstract][Full Text] [Related]
3. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
[TBL] [Abstract][Full Text] [Related]
4. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
[TBL] [Abstract][Full Text] [Related]
5. Modifications to the N-terminus but not the C-terminus of calcitonin gene-related peptide(8-37) produce antagonists with increased affinity.
Smith DD; Saha S; Fang G; Schaffert C; Waugh DJ; Zeng W; Toth G; Hulce M; Abel PW
J Med Chem; 2003 Jun; 46(12):2427-35. PubMed ID: 12773046
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
Salvatore CA; Hershey JC; Corcoran HA; Fay JF; Johnston VK; Moore EL; Mosser SD; Burgey CS; Paone DV; Shaw AW; Graham SL; Vacca JP; Williams TM; Koblan KS; Kane SA
J Pharmacol Exp Ther; 2008 Feb; 324(2):416-21. PubMed ID: 18039958
[TBL] [Abstract][Full Text] [Related]
7. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor.
Salvatore CA; Mallee JJ; Bell IM; Zartman CB; Williams TM; Koblan KS; Kane SA
Biochemistry; 2006 Feb; 45(6):1881-7. PubMed ID: 16460034
[TBL] [Abstract][Full Text] [Related]
8. Female sex steroid hormones and pregnancy regulate receptors for calcitonin gene-related peptide in rat mesenteric arteries, but not in aorta.
Yallampalli C; Kondapaka SB; Lanlua P; Wimalawansa SJ; Gangula PR
Biol Reprod; 2004 Apr; 70(4):1055-62. PubMed ID: 14668209
[TBL] [Abstract][Full Text] [Related]
9. Limitations in using peptide drugs to characterize calcitonin gene-related peptide receptors.
Waugh DJ; Bockman CS; Smith DD; Abel PW
J Pharmacol Exp Ther; 1999 Jun; 289(3):1419-26. PubMed ID: 10336535
[TBL] [Abstract][Full Text] [Related]
10. Effects of adrenomedullin on cyclic AMP formation and on relaxation in iris sphincter smooth muscle.
Yousufzai SY; Ali N; Abdel-Latif AA
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3245-53. PubMed ID: 10586949
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist.
Aiyar N; Daines RA; Disa J; Chambers PA; Sauermelch CF; Quiniou M; Khandoudi N; Gout B; Douglas SA; Willette RN
J Pharmacol Exp Ther; 2001 Mar; 296(3):768-75. PubMed ID: 11181905
[TBL] [Abstract][Full Text] [Related]
12. Desensitization and re-sensitization of CGRP receptor function in human neuroblastoma SK-N-MC cells.
Pin SS; Xu C; Bahr BA
Eur J Pharmacol; 2007 Dec; 577(1-3):7-16. PubMed ID: 17825280
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms.
Nikitenko LL; Blucher N; Fox SB; Bicknell R; Smith DM; Rees MC
J Cell Sci; 2006 Mar; 119(Pt 5):910-22. PubMed ID: 16495482
[TBL] [Abstract][Full Text] [Related]
14. Studies on the effects of the N-terminal domain antibodies of calcitonin receptor-like receptor and receptor activity-modifying protein 1 on calcitonin gene-related peptide-induced vasorelaxation in rat uterine artery.
Chauhan M; Gangula PR; Wimalawansa SJ; Yallampalli C
Biol Reprod; 2004 Jun; 70(6):1658-63. PubMed ID: 14960487
[TBL] [Abstract][Full Text] [Related]
15. Refolding and characterization of a soluble ectodomain complex of the calcitonin gene-related peptide receptor.
Koth CM; Abdul-Manan N; Lepre CA; Connolly PJ; Yoo S; Mohanty AK; Lippke JA; Zwahlen J; Coll JT; Doran JD; Garcia-Guzman M; Moore JM
Biochemistry; 2010 Mar; 49(9):1862-72. PubMed ID: 20099900
[TBL] [Abstract][Full Text] [Related]
16. Enhanced vascular responses to adrenomedullin in mice overexpressing receptor-activity-modifying protein 2.
Tam CW; Husmann K; Clark NC; Clark JE; Lazar Z; Ittner LM; Götz J; Douglas G; Grant AD; Sugden D; Poston L; Poston R; McFadzean I; Marber MS; Fischer JA; Born W; Brain SD
Circ Res; 2006 Feb; 98(2):262-70. PubMed ID: 16373602
[TBL] [Abstract][Full Text] [Related]
17. Deletions of genes encoding calcitonin/alpha-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone.
Lerner UH
J Musculoskelet Neuronal Interact; 2006; 6(1):87-95. PubMed ID: 16675892
[TBL] [Abstract][Full Text] [Related]
18. Cys2,7EtalphaCGRP is a potent agonist for CGRP1 receptors in SK-N-MC cells.
Nodin C; Vauquelin G; von Mentzer B
Biochem Pharmacol; 2005 Apr; 69(8):1235-40. PubMed ID: 15794944
[TBL] [Abstract][Full Text] [Related]
19. From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor.
Rist B; Entzeroth M; Beck-Sickinger AG
J Med Chem; 1998 Jan; 41(1):117-23. PubMed ID: 9438028
[TBL] [Abstract][Full Text] [Related]
20. Volatile anesthetics inhibit calcitonin gene-related peptide receptor-mediated responses in pithed rats and human neuroblastoma cells.
Kuroda M; Yoshikawa D; Nishikawa K; Saito S; Goto F
J Pharmacol Exp Ther; 2004 Dec; 311(3):1016-22. PubMed ID: 15297469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
